Creative Financial Designs’s Fulgent Genetics FLGT Stock Holding History

Creative Financial Designs’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250	Closed	-$6.68K	–	1613
2023 Q3	$6.68K	Hold	250	–	–	﹤0.01%	1124
2023 Q2	$9.26K	Sell	250 -200	-44%	-$6.97K	﹤0.01%	1034
2023 Q1	$14K	Hold	450	–	–	﹤0.01%	886
2022 Q4	$13.4K	Hold	450	–	–	﹤0.01%	851
2022 Q3	$17K	Hold	450	–	–	﹤0.01%	773
2022 Q2	$25K	Hold	450	–	–	﹤0.01%	688
2022 Q1	$28K	Hold	450	–	–	﹤0.01%	695
2021 Q4	$45K	Hold	450	–	–	0.01%	592
2021 Q3	$40K	Hold	450	–	–	0.01%	663
2021 Q2	$42K	Hold	450	–	–	0.01%	649
2021 Q1	$43K	Buy	+450	New	+$46.5K	0.01%	602

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creative Financial Designs's FLGT Position: Q4 2023 in Review

Creative Financial Designs sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 250 shares — an estimated $6.68K sold.

Creative Financial Designs first reported a position in FLGT in Q1 2021 and held it in 11 quarters. The position peaked at $45K in Q4 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

Creative Financial Designs reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
Creative Financial Designs sold 250 Fulgent Genetics shares in Q4 2023, an estimated $6.68K.
Creative Financial Designs first reported a position in Fulgent Genetics in Q1 2021 and held it in 11 quarters.
Creative Financial Designs's Fulgent Genetics position peaked at $45K in Q4 2021.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Creative Financial Designs's 13F filing for Q4 2023, filed 10 Jan 2024.